Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Tyme Technologies stock

Own Tyme Technologies stock in just a few minutes.

Tyme Technologies, Inc is a biotechnology business based in the US. Tyme Technologies shares (TYME) are listed on the NASDAQ and all prices are listed in US Dollars. Tyme Technologies employs 18 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Tyme Technologies

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – TYME – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Tyme Technologies share price

Use our graph to track the performance of TYME stocks over time.

Tyme Technologies shares at a glance

Information last updated 2021-04-23.
52-week range$0.85 - $3.48
50-day moving average $1.79
200-day moving average $1.55
Wall St. target price$9.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.28

Buy Tyme Technologies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Tyme Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Tyme Technologies financials

Gross profit TTM $0
Return on assets TTM -117.46%
Return on equity TTM -475.8%
Profit margin 0%
Book value $0.07
Market capitalisation $244.9 million

TTM: trailing 12 months

Shorting Tyme Technologies shares

There are currently 3.6 million Tyme Technologies shares held short by investors – that's known as Tyme Technologies's "short interest". This figure is 26.1% up from 2.9 million last month.

There are a few different ways that this level of interest in shorting Tyme Technologies shares can be evaluated.

Tyme Technologies's "short interest ratio" (SIR)

Tyme Technologies's "short interest ratio" (SIR) is the quantity of Tyme Technologies shares currently shorted divided by the average quantity of Tyme Technologies shares traded daily (recently around 3.2 million). Tyme Technologies's SIR currently stands at 1.14. In other words for every 100,000 Tyme Technologies shares traded daily on the market, roughly 1140 shares are currently held short.

However Tyme Technologies's short interest can also be evaluated against the total number of Tyme Technologies shares, or, against the total number of tradable Tyme Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tyme Technologies's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Tyme Technologies shares in existence, roughly 20 shares are currently held short) or 0.0302% of the tradable shares (for every 100,000 tradable Tyme Technologies shares, roughly 30 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Tyme Technologies.

Find out more about how you can short Tyme Technologies stock.

Tyme Technologies share dividends

We're not expecting Tyme Technologies to pay a dividend over the next 12 months.

Have Tyme Technologies's shares ever split?

Tyme Technologies's shares were split on a 4:1 basis on 25 September 2014. So if you had owned 1 share the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Tyme Technologies shares – just the quantity. However, indirectly, the new 75% lower share price could have impacted the market appetite for Tyme Technologies shares which in turn could have impacted Tyme Technologies's share price.

Tyme Technologies share price volatility

Over the last 12 months, Tyme Technologies's shares have ranged in value from as little as $0.85 up to $3.48. A popular way to gauge a stock's volatility is its "beta".

TYME.US volatility(beta: 1.03)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tyme Technologies's is 1.0314. This would suggest that Tyme Technologies's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Tyme Technologies overview

Tyme Technologies, Inc. , a clinical-stage biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead candidate is the SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, lung, breast, prostate, sarcoma, and lymphoma. The company also offers TYME-18, a CMBT compound that is in preclinical stage for the treatment of solid tumors. Tyme Technologies, Inc. has a research collaboration with NYU Langone Health to advance the development of treatments for patients with metastatic cancers, including pancreatic cancer, as well as with Mayo Clinic; and a strategic collaboration with Eagle Pharmaceuticals, Inc. to advance oral SM-88 for the treatment of patients with cancer.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site